This protocol is judged by an institutional evaluate board, an unbiased team that critiques any medical trials involving humans. If a research consists of a Program I drug, after the board approves the protocol as ethical, the scientists need to make an application for an investigational new drug (IND) amount from your FDA.Some scientists and compa